As of October 29, 2026, Sarepta Therapeutics had a market cap of $2.031 billion, which decreased by 0.49% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Data updated: Oct 29, 2026, 4:00 PM ET
Sarepta Therapeutics Inc. (SRPT)
🌍 United States📈 NASDAQ🏭 Health Care🏢 Biotechnology
Note: Each point on the chart represents the market capitalization at the end of the trading day. Source: Data compiled from
EDGAR filings,
Bloomberg
and Yahoo Finance.
📈 Sarepta Therapeutics Market Cap History by Year and Month
Sarepta Therapeutics Market Cap History by Year and Month
Year / Month
Market Cap
% Change
2026
$2.031B
▼ 9.93%
$2.031B
▲ 5.56%
$1.924B
▼ 13.37%
$2.221B
▲ 41.56%
$1.569B
▼ 17.29%
$1.897B
▲ 0.53%
$1.887B
▼ 13.91%
$2.192B
▼ 4.07%
$2.285B
▲ 30.13%
$1.756B
▼ 17.60%
$2.131B
▼ 5.50%
2025
$2.255B
▼ 80.86%
$2.255B
▲ 0.85%
$2.236B
▼ 11.02%
$2.513B
▲ 24.59%
$2.017B
▲ 13.44%
$1.778B
▲ 10.16%
$1.614B
▼ 3.99%
$1.681B
▼ 54.51%
$3.695B
▼ 39.73%
$6.131B
▼ 2.23%
$6.271B
▼ 39.47%
$10.36B
▼ 5.99%
$11.02B
▼ 6.47%
2024
$11.782B
▲ 30.61%
$11.782B
▼ 7.50%
$12.737B
▲ 5.86%
$12.032B
▲ 0.89%
$11.926B
▼ 7.90%
$12.949B
▼ 4.46%
$13.553B
▼ 9.25%
$14.934B
▲ 21.67%
$12.274B
▲ 2.52%
$11.972B
▼ 1.47%
$12.151B
▲ 1.22%
$12.005B
▲ 7.64%
$11.153B
▲ 23.63%
2023
$9.021B
▼ 20.69%
$9.021B
▲ 18.63%
$7.604B
▲ 20.76%
$6.297B
▼ 44.31%
$11.307B
▲ 0.17%
$11.288B
▲ 11.64%
$10.111B
▼ 5.34%
$10.681B
▼ 7.23%
$11.513B
▲ 0.67%
$11.436B
▼ 10.91%
$12.837B
▲ 19.47%
$10.745B
▼ 2.24%
$10.991B
▼ 3.38%
2022
$11.375B
▲ 44.98%
$11.375B
▲ 5.52%
$10.78B
▲ 7.70%
$10.009B
▲ 3.16%
$9.702B
▲ 1.29%
$9.578B
▲ 17.67%
$8.14B
▲ 24.05%
$6.562B
▲ 2.98%
$6.372B
▲ 0.70%
$6.328B
▼ 7.43%
$6.836B
▲ 2.38%
$6.677B
▲ 7.07%
$6.236B
▼ 20.52%
2021
$7.846B
▼ 42.02%
$7.846B
▲ 11.50%
$7.037B
▲ 2.12%
$6.891B
▼ 6.82%
$7.395B
▲ 18.57%
$6.237B
▲ 15.24%
$5.412B
▼ 12.79%
$6.206B
▲ 2.83%
$6.035B
▲ 6.80%
$5.651B
▼ 4.93%
$5.944B
▼ 14.03%
$6.914B
▼ 2.56%
$7.096B
▼ 47.56%
2020
$13.532B
▲ 39.49%
$13.532B
▲ 21.75%
$11.115B
▲ 3.64%
$10.725B
▼ 3.06%
$11.064B
▼ 3.75%
$11.495B
▼ 4.63%
$12.053B
▼ 4.15%
$12.575B
▲ 5.89%
$11.876B
▲ 29.23%
$9.19B
▲ 20.51%
$7.626B
▼ 14.34%
$8.903B
▲ 2.12%
$8.718B
▼ 10.13%
2019
$9.701B
▲ 25.08%
$9.701B
▲ 15.69%
$8.385B
▲ 35.50%
$6.188B
▲ 10.28%
$5.611B
▼ 16.28%
$6.702B
▼ 39.43%
$11.064B
▼ 1.80%
$11.267B
▲ 33.46%
$8.442B
▼ 2.63%
$8.67B
▼ 1.57%
$8.808B
▼ 14.34%
$10.283B
▲ 3.57%
$9.929B
▲ 28.02%
2018
$7.756B
▲ 115.68%
$7.756B
▼ 15.56%
$9.185B
▲ 2.76%
$8.938B
▼ 16.71%
$10.731B
▲ 17.01%
$9.171B
▲ 18.90%
$7.713B
▼ 10.96%
$8.662B
▲ 40.85%
$6.15B
▲ 22.90%
$5.004B
▲ 3.95%
$4.814B
▲ 18.02%
$4.079B
▼ 3.93%
$4.246B
▲ 18.08%
2017
$3.596B
▲ 140.21%
$3.596B
▼ 0.06%
$3.598B
▲ 12.90%
$3.187B
▲ 9.22%
$2.918B
▲ 12.58%
$2.592B
▲ 4.43%
$2.482B
▲ 33.01%
$1.866B
▲ 13.78%
$1.64B
▼ 17.71%
$1.993B
▲ 22.57%
$1.626B
▼ 4.63%
$1.705B
▲ 0.24%
$1.701B
▲ 13.63%
2016
$1.497B
▼ 14.94%
$1.497B
▼ 19.95%
$1.87B
▼ 12.33%
$2.133B
▼ 36.10%
$3.338B
▲ 167.25%
$1.249B
▲ 3.22%
$1.21B
▲ 32.53%
$0.913B
▼ 4.70%
$0.958B
▲ 47.61%
$0.649B
▼ 27.32%
$0.893B
▲ 42.65%
$0.626B
▲ 15.50%
$0.542B
▼ 69.20%
2015
$1.76B
▲ 194.31%
$1.76B
▲ 5.77%
$1.664B
▲ 52.80%
$1.089B
▼ 19.15%
$1.347B
▼ 9.11%
$1.482B
▲ 11.85%
$1.325B
▲ 4.91%
$1.263B
▲ 18.93%
$1.062B
▲ 109.88%
$0.506B
▼ 7.83%
$0.549B
▼ 4.36%
$0.574B
▲ 15.73%
$0.496B
▼ 17.06%
2014
$0.598B
▼ 22.24%
$0.598B
▼ 14.57%
$0.7B
▲ 4.79%
$0.668B
▼ 23.31%
$0.871B
▼ 7.14%
$0.938B
▲ 7.45%
$0.873B
▼ 28.15%
$1.215B
▼ 11.31%
$1.37B
▼ 9.27%
$1.51B
▲ 65.39%
$0.913B
▼ 16.77%
$1.097B
▲ 19.24%
$0.92B
▲ 19.64%
2013
$0.769B
▼ 5.99%
$0.769B
▲ 9.86%
$0.7B
▼ 52.15%
$1.463B
▼ 17.48%
$1.773B
▲ 54.98%
$1.144B
▼ 7.74%
$1.24B
▲ 2.14%
$1.214B
▲ 7.62%
$1.128B
▲ 21.68%
$0.927B
▼ 21.17%
$1.176B
▲ 26.05%
$0.933B
▲ 8.87%
$0.857B
▲ 4.77%
2012
$0.818B
▲ 701.96%
$0.818B
▲ 9.65%
$0.746B
▲ 37.38%
$0.543B
▲ 54.70%
$0.351B
▼ 1.96%
$0.358B
▲ 74.63%
$0.205B
▲ 139.75%
$85.504M
▼ 3.08%
$88.218M
▼ 21.93%
$0.113B
▼ 45.93%
$0.209B
▲ 48.23%
$0.141B
▲ 15.57%
$0.122B
▲ 19.61%
2011
$0.102B
▼ 57.14%
$0.102B
▲ 2.95%
$99.076M
▼ 25.51%
$0.133B
▼ 12.50%
$0.152B
▼ 9.52%
$0.168B
▼ 16.00%
$0.2B
▲ 3.09%
$0.194B
▼ 11.01%
$0.218B
▼ 10.29%
$0.243B
▲ 16.27%
$0.209B
▼ 7.11%
$0.225B
▼ 7.79%
$0.244B
▲ 2.52%
2010
$0.238B
▲ 47.83%
$0.238B
▲ 14.98%
$0.207B
▼ 13.03%
$0.238B
▲ 15.53%
$0.206B
▼ 11.97%
$0.234B
▲ 8.84%
$0.215B
▲ 20.79%
$0.178B
▲ 12.66%
$0.158B
▲ 8.22%
$0.146B
▲ 12.31%
$0.13B
▼ 18.24%
$0.159B
▼ 1.24%
$0.161B
— 0.00%
2009
$0.161B
▲ 242.80%
$0.161B
▲ 2.55%
$0.157B
▼ 3.09%
$0.162B
▼ 14.74%
$0.19B
▲ 29.25%
$0.147B
▼ 25.38%
$0.197B
▲ 45.93%
$0.135B
▲ 29.81%
$0.104B
▲ 49.96%
$69.352M
▲ 22.73%
$56.509M
▲ 32.35%
$42.696M
▼ 31.03%
$61.909M
▲ 31.82%
2008
$46.966M
▼ 48.31%
$46.966M
▲ 1.57%
$46.24M
▼ 24.44%
$61.198M
▼ 28.93%
$86.104M
▲ 7.95%
$79.766M
▼ 8.79%
$87.453M
▲ 9.82%
$79.632M
▼ 19.86%
$99.372M
▼ 6.25%
$0.106B
▼ 18.46%
$0.13B
▲ 48.34%
$87.638M
▲ 9.68%
$79.906M
▼ 12.06%
2007
$90.86M
▼ 45.92%
$90.86M
▼ 27.31%
$0.125B
▼ 17.76%
$0.152B
▲ 10.95%
$0.137B
▼ 2.14%
$0.14B
▲ 0.72%
$0.139B
▼ 7.33%
$0.15B
▼ 8.54%
$0.164B
▲ 14.69%
$0.143B
— 0.00%
$0.143B
▲ 1.42%
$0.141B
▼ 12.42%
$0.161B
▼ 4.17%
2006
$0.168B
▲ 10.53%
$0.168B
▼ 12.50%
$0.192B
▼ 6.80%
$0.206B
▲ 6.74%
$0.193B
▼ 11.87%
$0.219B
▲ 46.00%
$0.15B
▼ 24.62%
$0.199B
▼ 17.43%
$0.241B
▼ 28.49%
$0.337B
▼ 16.17%
$0.402B
▲ 2.55%
$0.392B
▼ 10.09%
$0.436B
▲ 186.84%
2005
$0.152B
▲ 78.95%
$0.152B
▲ 2.70%
$0.148B
▼ 5.73%
$0.157B
▲ 34.19%
$0.117B
▲ 23.16%
$94.996M
▼ 7.77%
$0.103B
— 0.00%
$0.103B
▼ 0.96%
$0.104B
▼ 11.86%
$0.118B
▲ 7.27%
$0.11B
▲ 17.51%
$93.613M
▼ 1.52%
$95.059M
▲ 11.92%
2004
$84.938M
▼ 39.33%
$84.938M
▲ 8.35%
$78.393M
▼ 3.56%
$81.284M
▲ 9.76%
$74.058M
▼ 24.35%
$97.902M
▲ 34.16%
$72.975M
▼ 15.83%
$86.702M
▲ 6.28%
$81.577M
▼ 21.56%
$0.104B
▼ 4.59%
$0.109B
▼ 8.40%
$0.119B
▼ 16.20%
$0.142B
▲ 1.43%
2003
$0.14B
▲ 5.26%
$0.14B
▼ 8.50%
$0.153B
▲ 1.32%
$0.151B
▼ 6.21%
$0.161B
▼ 6.94%
$0.173B
▲ 11.61%
$0.155B
▼ 17.11%
$0.187B
▲ 10.00%
$0.17B
▲ 1.80%
$0.167B
▲ 82.20%
$91.66M
▲ 9.20%
$83.936M
▼ 33.91%
$0.127B
▼ 4.51%
2002
$0.133B
▼ 47.64%
$0.133B
▼ 13.64%
$0.154B
▲ 12.41%
$0.137B
▼ 2.14%
$0.14B
▲ 33.33%
$0.105B
▲ 7.32%
$97.835M
▲ 26.42%
$77.387M
▼ 39.54%
$0.128B
▼ 32.63%
$0.19B
▲ 0.53%
$0.189B
▼ 12.09%
$0.215B
▼ 20.96%
$0.272B
▲ 7.09%
2001
$0.254B
▲ 149.02%
$0.254B
▲ 14.93%
$0.221B
▲ 24.16%
$0.178B
▲ 4.09%
$0.171B
▼ 6.04%
$0.182B
▼ 22.88%
$0.236B
▲ 11.32%
$0.212B
▲ 16.48%
$0.182B
▲ 23.81%
$0.147B
▲ 68.08%
$87.458M
▼ 27.72%
$0.121B
▼ 15.38%
$0.143B
▲ 40.20%
2000
$0.102B
▲ 15.54%
$0.102B
▼ 21.54%
$0.13B
▼ 2.99%
$0.134B
▼ 7.59%
$0.145B
▼ 14.20%
$0.169B
▲ 32.03%
$0.128B
▼ 22.42%
$0.165B
▼ 0.60%
$0.166B
▲ 8.50%
$0.153B
▼ 26.44%
$0.208B
▼ 51.06%
$0.425B
▲ 127.27%
$0.187B
▲ 111.82%
1999
$88.283M
▲ 65.40%
$88.283M
▼ 2.03%
$90.113M
▲ 66.16%
$54.234M
▲ 20.37%
$45.056M
▲ 5.88%
$42.553M
▼ 20.31%
$53.4M
▲ 16.36%
$45.891M
— 0.00%
$45.891M
▼ 5.17%
$48.394M
▲ 26.09%
$38.381M
▼ 11.50%
$43.368M
▼ 7.14%
$46.704M
▼ 12.50%
1998
$53.376M
▼ 29.57%
$53.376M
▲ 6.71%
$50.018M
▼ 13.04%
$57.52M
▲ 27.78%
$45.016M
▲ 0.73%
$44.688M
▼ 18.99%
$55.162M
▼ 21.00%
$69.825M
▼ 10.62%
$78.12M
▼ 3.45%
$80.91M
▲ 1.75%
$79.515M
▼ 2.25%
$81.344M
▲ 10.38%
$73.697M
▼ 2.75%
1997
$75.782M
▲ 12.12%
$75.782M
▼ 14.82%
$88.962M
▼ 2.27%
$91.031M
▲ 14.78%
$79.307M
▲ 27.40%
$62.252M
▼ 1.87%
$63.438M
▼ 6.14%
$67.588M
— 0.00%
All market cap values reflect closing prices for the period shown.
📊 Sarepta Therapeutics Market Cap and Other Industry Peers
Below are selected companies from the Biotechnology sector / subsector: